Michael Winkelmann

901 total citations
38 papers, 372 citations indexed

About

Michael Winkelmann is a scholar working on Oncology, Neurology and Epidemiology. According to data from OpenAlex, Michael Winkelmann has authored 38 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 8 papers in Neurology and 8 papers in Epidemiology. Recurrent topics in Michael Winkelmann's work include CAR-T cell therapy research (14 papers), Neuroendocrine Tumor Research Advances (7 papers) and Lung Cancer Research Studies (7 papers). Michael Winkelmann is often cited by papers focused on CAR-T cell therapy research (14 papers), Neuroendocrine Tumor Research Advances (7 papers) and Lung Cancer Research Studies (7 papers). Michael Winkelmann collaborates with scholars based in Germany, United States and Slovakia. Michael Winkelmann's co-authors include Wolfgang G. Kunz, Risa M. Webb, Lyle R. Petersen, A. Arturo Leis, Anthony A. Marfin, Dobrivoje S. Stokić, Sally Slavinski, James J. Sejvar, Jay A. van Gerpen and Bruce C. Tierney and has published in prestigious journals such as Blood, European Journal of Immunology and Emerging infectious diseases.

In The Last Decade

Michael Winkelmann

33 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Winkelmann Germany 8 126 111 98 51 46 38 372
Neelam Pushker India 15 118 0.9× 76 0.7× 44 0.4× 128 2.5× 41 0.9× 42 690
R. Benmously Tunisia 10 45 0.4× 59 0.5× 45 0.5× 100 2.0× 30 0.7× 51 307
Denise Bonney United Kingdom 18 180 1.4× 86 0.8× 136 1.4× 155 3.0× 164 3.6× 41 881
J Baró Spain 11 107 0.8× 50 0.5× 75 0.8× 79 1.5× 35 0.8× 30 366
Fidan Jmor United Kingdom 9 78 0.6× 42 0.4× 63 0.6× 63 1.2× 45 1.0× 9 320
I. Mokhtar Tunisia 9 38 0.3× 73 0.7× 49 0.5× 126 2.5× 22 0.5× 34 307
Olga López Spain 4 140 1.1× 33 0.3× 71 0.7× 80 1.6× 113 2.5× 6 347
Eduard Schulz United States 10 75 0.6× 30 0.3× 119 1.2× 94 1.8× 31 0.7× 44 437
Jiehao Zhou United States 9 63 0.5× 21 0.2× 80 0.8× 47 0.9× 217 4.7× 14 432
Ann‐Marie Lobo United States 9 86 0.7× 72 0.6× 11 0.1× 129 2.5× 64 1.4× 23 526

Countries citing papers authored by Michael Winkelmann

Since Specialization
Citations

This map shows the geographic impact of Michael Winkelmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Winkelmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Winkelmann more than expected).

Fields of papers citing papers by Michael Winkelmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Winkelmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Winkelmann. The network helps show where Michael Winkelmann may publish in the future.

Co-authorship network of co-authors of Michael Winkelmann

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Winkelmann. A scholar is included among the top collaborators of Michael Winkelmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Winkelmann. Michael Winkelmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leithner, Doris, Emanuele Neri, Melvin D’Anastasi, et al.. (2025). ESR Essentials: imaging of lymphoma—practice recommendations by the European Society of Oncologic Imaging. European Radiology. 35(7). 4387–4394. 1 indexed citations
2.
Winkelmann, Michael, et al.. (2025). Bildgebende Primärdiagnostik bei Lymphomen. Die Radiologie. 65(7). 500–507.
3.
Marcon, Julian, Philipp Weinhold, Matthias P. Fabritius, et al.. (2025). Radiomics-based differentiation of upper urinary tract urothelial and renal cell carcinoma in preoperative computed tomography datasets. BMC Medical Imaging. 25(1). 196–196.
4.
Auernhammer, Christoph J., Roberto Lorbeer, Michael Winkelmann, et al.. (2024). Utility of clinical and MR imaging parameters for prediction and monitoring of response to capecitabine and temozolomide (CAPTEM) therapy in patients with liver metastases of neuroendocrine tumors. Radiology and Oncology. 58(2). 196–205. 1 indexed citations
5.
Unterrainer, Lena M., Wolfgang G. Kunz, Michael Winkelmann, et al.. (2024). Lenticulostriatal Ischemia Shows Relevant SSTR Expression on PET/CT Imaging Using the Novel SSTR-Targeting Peptide 18F-SiTATE. Clinical Nuclear Medicine. 49(12). e689–e690. 1 indexed citations
6.
Rejeski, Kai, David M. Cordas dos Santos, Nathan H. Parker, et al.. (2023). Influence of Adipose Tissue Distribution, Sarcopenia, and Nutritional Status on Clinical Outcomes After CD19 CAR T-cell Therapy. Cancer Immunology Research. 11(6). 707–719. 20 indexed citations
7.
Winkelmann, Michael, Viktoria Blumenberg, Kai Rejeski, et al.. (2023). Modification of Lugano criteria by pre-infusion tumor kinetics improves early survival prediction for patients with lymphoma under chimeric antigen receptor T-cell therapy. Journal for ImmunoTherapy of Cancer. 11(10). e006659–e006659.
8.
Geyer, Thomas, Leonie Beyer, Michael Winkelmann, et al.. (2023). Validation of the SSTR-RADS 1.0 for the structured interpretation of SSTR-PET/CT and treatment planning in neuroendocrine tumor (NET) patients. European Radiology. 33(5). 3416–3424. 6 indexed citations
9.
Winkelmann, Michael, Caroline Burgard, Christine Schmid‐Tannwald, et al.. (2023). Reliability and practicability of PSMA-RADS 1.0 for structured reporting of PSMA-PET/CT scans in prostate cancer patients. European Radiology. 34(2). 1157–1166. 7 indexed citations
10.
Auernhammer, Christoph J., Vera Wenter, Michael Winkelmann, et al.. (2023). Quantitative SSTR-PET/CT for predicting response and survival outcomes in patients with pancreatic neuroendocrine tumors receiving CAPTEM. Radiology and Oncology. 57(4). 436–445. 1 indexed citations
11.
Winkelmann, Michael, Viktoria Blumenberg, Kai Rejeski, et al.. (2023). Staging of lymphoma under chimeric antigen receptor T-cell therapy: reasons for discordance among imaging response criteria. Cancer Imaging. 23(1). 44–44. 1 indexed citations
12.
Winkelmann, Michael, Matthias P. Fabritius, Jens Ricke, et al.. (2023). Neuroendocrine liver metastases treated using transarterial radioembolization: Identification of prognostic parameters at 68Ga-DOTATATE PET/CT. Diagnostic and Interventional Imaging. 105(1). 15–25. 5 indexed citations
13.
Winkelmann, Michael, Viktoria Blumenberg, Kai Rejeski, et al.. (2022). Prognostic value of the International Metabolic Prognostic Index for lymphoma patients receiving chimeric antigen receptor T-cell therapy. European Journal of Nuclear Medicine and Molecular Imaging. 50(5). 1406–1413. 12 indexed citations
14.
Santos, David M. Cordas dos, Kai Rejeski, Michael Winkelmann, et al.. (2022). Increased visceral fat distribution and body composition impact cytokine release syndrome onset and severity after CD19 chimeric antigen receptor T-cell therapy in advanced B-cell malignancies. Haematologica. 107(9). 2096–2107. 24 indexed citations
15.
Winkelmann, Michael, Veit Bücklein, Viktoria Blumenberg, et al.. (2022). Lymphoma tumor burden before chimeric antigen receptor T-Cell treatment: RECIL vs. Lugano vs. metabolic tumor assessment. Frontiers in Oncology. 12. 974029–974029. 7 indexed citations
16.
17.
Unterrainer, Marcus, Matthias P. Fabritius, Lena M. Mittlmeier, et al.. (2020). PET/CT imaging for tumour response assessment to immunotherapy: current status and future directions. European Radiology Experimental. 4(1). 63–63. 36 indexed citations
18.
Gontkovsky, Samuel T., et al.. (2007). Decreased Serum Glucose Levels after??Initiation of Methylphenidate in??a??Patient Status Post-Cerebellar Tumour Resection. Clinical Drug Investigation. 27(10). 719–725. 3 indexed citations
19.
Winkelmann, Michael, et al.. (1985). Kapitalmarkteffizienz und Point & Figure Analyse. Credit and Capital Markets – Kredit und Kapital. 18(2). 240–264.
20.
Winkelmann, Michael. (1984). Aktienbewertung in Deutschland. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Neelam Pushker Breakdown of academic impact, for papers by R. Benmously Breakdown of academic impact, for papers by Denise Bonney Breakdown of academic impact, for papers by J Baró Breakdown of academic impact, for papers by Fidan Jmor Breakdown of academic impact, for papers by I. Mokhtar Breakdown of academic impact, for papers by Olga López Breakdown of academic impact, for papers by Eduard Schulz Breakdown of academic impact, for papers by Jiehao Zhou Breakdown of academic impact, for papers by Ann‐Marie Lobo
Rankless by CCL
2026